Rocuronium Fresenius rocuronium bromide 50mg/5mL solution for injection vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

rocuronium bromide, Quantity: 10 g/L

Disponível em:

Fresenius Kabi Australia Pty Ltd

DCI (Denominação Comum Internacional):

Rocuronium bromide

Forma farmacêutica:

Injection, solution

Composição:

Excipient Ingredients: water for injections; glacial acetic acid; sodium acetate trihydrate; sodium chloride

Via de administração:

Intravenous

Unidades em pacote:

10 x 5mL, 5 x 5mL

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

INDICATIONS,Rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, children and infants over 1 month of age.,Rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated, however, this has not been studied in infants and children.,Rocuronium is also indicated as an adjunct in the intensive care unit (ICU) to facilitate mechanical ventilation.

Resumo do produto:

Visual Identification: A clear, colourless to pale brownish-yellow solution.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius

Status de autorização:

Licence status A

Data de autorização:

2014-11-12